Skip to main content

Day: February 4, 2022

Shockwave Medical to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

SANTA CLARA, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company will be participating in the SVB Leerink 11th Annual Global Healthcare Conference, scheduled to be held virtually from February 14-18, 2022. Shockwave management is scheduled for a fireside chat on Friday, February 18, 2022, at 3:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the “Investors” section of the company’s website at https://ir.shockwavemedical.com. About Shockwave Medical, Inc. Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated....

Continue reading

Alimera Sciences to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference

ATLANTA, Feb. 04, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer will present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference, which is being held virtually from February 8 – 11, 2022. Mr. Eiswirth will deliver his corporate presentation on Wednesday, February 9 at 10:00 AM ET. Event Webcast URL: https://www.webcaster4.com/Webcast/Page/2840/44550 Mr. Eiswirth and Phil Jones, Alimera’s Chief Financial Officer, will be available for one-on-one investor meetings on February 10 – 11, 2022. To receive additional information...

Continue reading

Reservoir Strikes Deal With Nashville Songwriters Hall of Fame Member Buddy Cannon

NEW YORK, Feb. 04, 2022 (GLOBE NEWSWIRE) — Reservoir Media, Inc. (NASDAQ: RSVR) (“Reservoir” or the “Company”), an award-winning independent music company, today announced the acquisition of the producer catalog of Nashville Songwriters Hall of Fame member Buddy Cannon. The deal includes rights to all of Cannon’s Kenny Chesney collaborations from 1997’s I Will Stand through 2017’s Live In No Shoes Nation. Cannon’s collaborative relationship with Kenny Chesney spans more than 20 years, and the music they created together has led to more than three billion streams, 31 million album sales, and 36 million track sales. Among the most successful titles Cannon contributed to are double-Platinum “American Kids,” two-time Grammy-nominated and Platinum-certified “You and Tequila” featuring Grace Potter, and Platinum-certified...

Continue reading

SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting

BOULDER, Colo., Feb. 04, 2022 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual analyst and investor meeting today, February 4th, 2022, from 10:00 a.m. to approximately 1:00 p.m. Eastern Time. The event is intended to highlight recent corporate updates, technical specifications and capabilities of the SomaScan platform, and various applications across life science tools and clinical diagnostics. SomaLogic management will be joined by leading experts and partners to discuss several ongoing initiatives demonstrating the vast potential for proteomics to deliver meaningful insights that can positively impact human health. 2022 Revenue Guidance In conjunction with the event, SomaLogic is providing full-year 2022 revenue guidance. Management projects 2022 revenue of approximately...

Continue reading

APA Corporation Declares Cash Dividend on Common Shares

HOUSTON, Feb. 04, 2022 (GLOBE NEWSWIRE) — The board of directors of APA Corporation (Nasdaq: APA) has declared a regular cash dividend on the company’s common shares. The dividend on common shares is payable May 23, 2022, to stockholders of record on April 22, 2022, at a rate of 12.5 cents per share on the corporation’s common stock. About APA APA Corporation owns consolidated subsidiaries that explore for and produce oil and gas in the United States, Egypt and the United Kingdom and that explore for oil and gas offshore Suriname. APA posts announcements, operational updates, investor information and press releases on its website, www.apacorp.com. Specific information concerning Suriname, ESG performance and other investor-related topics are posted at investor.apacorp.com. ContactsInvestor:   (281) 302-2286   Gary ClarkMedia:   (713)...

Continue reading

Purple Biotech Issues Letter to Shareholders

REHOVOT, Israel, Feb. 04, 2022 (GLOBE NEWSWIRE) —   Purple Biotech Ltd. (“Purple Biotech”, or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, is pleased to issue the following letter from its Chief Executive Officer, Isaac Israel, to its shareholders. View as PDF Dear shareholders, I look back at 2021 proudly as a foundation-setting year for Purple Biotech, one with clinical development achievements, personnel and culture advancements. Through our collaborations, products and people, we continue to advocate for and work towards the realization of our mission to move individuals from cancer patients to cancer survivors. I am pleased with the meaningful progress we have made toward...

Continue reading

Islandsbanki hf.: Íslandsbanki’s Nomination Committee requests proposals for candidates to serve on the Bank’s Board of Directors

Íslandsbanki‘s Annual General Meeting will be held on 17 March 2022 at 16:00 (GMT). The Bank’s Nomination Committee has an advisory role when it comes to the election of Board members and submits a reasoned proposal at shareholders’ meetings where election of Board members is on the agenda, of candidates to serve on the Board. For further information on the Committee’s role, please see the Committee’s Rules of Procedure, which can be accessed here. The Bank’s Nomination Committee invites those interested to submit their candidacies to the Committee. Deadline for declaring candidacy to the Nomination Committee expires at 16:00 (GMT) on 21 February, the Committee will not assess candidates who submit their candidacy after this deadline. The Committee intends to publish its proposal on 3 March 2022. Candidates are requested to fill out the...

Continue reading

Issuances in Prospect Capital Corporation Preferred Stock Offerings Exceed $500 Million Across Institutional, Registered Investment Advisor, Wirehouse, Independent Private Wealth, and International Investors 

NEW YORK, Feb. 04, 2022 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced today that Prospect’s preferred stock offerings (collectively, the “Preferred Stock”) have exceeded $500 million in aggregate liquidation preference issuances since the initial closing in the quarter ending December 31, 2020. “Prospect’s preferred stock offers investors recurring cash income with a stable stated value, ongoing liquidity, management alignment, leverage caps, and nearly $4 billion of junior common equity credit support.” said Grier Eliasek, President of Prospect. “Each of the institutional, registered investment advisor, wirehouse, independent private wealth, and international investor channels have invested in Prospect’s preferred stock.” Preferred Capital Securities...

Continue reading

REPEAT – Standard Lithium Comments on Short Seller Report

VANCOUVER, British Columbia, Feb. 04, 2022 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), is issuing the following statement in response to the false and misleading report (the “report”) from Hindenburg Research. Standard Lithium believes the report is clearly intended to benefit Hindenburg Research, which itself has disclosed that it stands to profit in the event that the stock price of Standard Lithium declines. Standard Lithium cautions investors not to make decisions based on this report and instead strongly encourages them to consult credible and informed sources, including Standard Lithium’s filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission prior to making investment decisions. Standard Lithium ManagementSince...

Continue reading

Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 18, 2022

NEW HAMPTON, N.Y., Feb. 04, 2022 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 18th at 11:00 AM Eastern Time (ET) to review fourth quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO will host the call. Fourth quarter results will be published prior to the market opening on Friday, February 18, 2022. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.